Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Promising strategies employing nucleic acids as antimicrobial drugs
Publication

Publications

Promising strategies employing nucleic acids as antimicrobial drugs

Title
Promising strategies employing nucleic acids as antimicrobial drugs
Type
Another Publication in an International Scientific Journal
Year
2024
Authors
Moreira, L
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Guimaraes, NM
(Author)
FEUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Santos, RS
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Pereira, MC
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Azevedo, NF
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Vol. 35
Publisher: Elsevier
Indexing
Publicação em ISI Web of Knowledge ISI Web of Knowledge - 0 Citations
Publicação em Scopus Scopus - 0 Citations
Other information
Authenticus ID: P-00Z-XHC
Abstract (EN): Antimicrobial resistance (AMR) is a growing concern because it causes microorganisms to develop resistance to drugs commonly used to treat infections. This results in increased difficulty in treating infections, leading to higher mortality rates and significant economic effects. Investing in new antimicrobial agents is, therefore, necessary to prevent and control AMR. Antimicrobial nucleic acids have arisen as potential key players in novel therapies for AMR infections. They have been designed to serve as antimicrobials and to act as adjuvants to conventional antibiotics or to inhibit virulent mechanisms. This new category of antimicrobial drugs consists of antisense oligonucleotides and oligomers, DNAzymes, and transcription factor decoys, differing in terms of structure, target molecules, and mechanisms of action. They are synthesized using nucleic acid analogs to enhance their resistance to nucleases. Because bacterial envelopes are generally impermeable to oligonucleotides, delivery into the cytoplasm typically requires the assistance of nanocarriers, which can affect their therapeutic potency. Given that numerous factors contribute to the success of these antimicrobial drugs, this review aims to provide a summary of the key advancements in the use of oligonucleotides for treating bacterial infections. Their mechanisms of action and the impact of factors such as nucleic acid design, target sequence, and nanocarriers on the antimicrobial potency are discussed.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 24
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

miRNA-31 Improves Cognition and Abolishes Amyloid-beta Pathology by Targeting APP and BACE1 in an Animal Model of Alzheimer's Disease (2020)
Article in International Scientific Journal
Barros Viegas, AT; Carmona, V; Ferreiro, E; Guedes, J; Cardoso, AM; Cunha, P; de Almeida, LP; de Oliveira, CR; de Magalhaes, JP; Peca, J; Cardoso, AL
Effect of Native Gastric Mucus on in vivo Hybridization Therapies Directed at Helicobacter pylori (2015)
Article in International Scientific Journal
Rita S. Santos; George R. Dakwar; Ranhua Xiong ; Katrien Forier ; Katrien Remaut ; Stephan Stremersch; Nuno Guimarães; Sílvia Fontenete ; Jesper Wengel ; Marina Leite; Céu Figueiredo; Stefaan C. De Smedt; Kevin Braeckmans; Nuno F. Azevedo
Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-16 at 23:35:10 | Privacy Policy | Personal Data Protection Policy | Whistleblowing